October 2015
Balmain biotech has 10 shots at billions
The journey from CSIRO test tube to US Food and Drug Administration approval is one that few medical technologies survive, but Balmain-based Benitec is trying 10 different routes for its "gene-silencing" treatment, including one potential shortcut through the FDA process.
- Updated
- Michael Bailey
August 2015
Scared Australian investors miss out on big biotech returns
US investors are snapping up promising Australian biotech firms, while Australian fund managers who don't understand the sector stick to blue-chip stocks like banks, miners, telcos and utilities.
- Updated
- John Kehoe
June 2014
Biotech sector cashed up and confident, but slam lack of government support
Biotechnology companies are cashed up and confident but believe the government lacks a coherent plan to ensure that their industry prospers.
- Jessica Gardner
March 2010
Company briefs
BHP Billiton restarted operations at its 60,000 tonne a year Kwinana refinery in Western Australia yesterday.
Brief: Benitec
Benitecreports Sue MacLeman will step down as CEO and MD. Ms MacLeman has been appointed CEO of Progen Pharmaceuticals.
- Updated
January 2008
Briefs
Mincor buys out View
- Staff reporter, Tracy Lee, Fiona Tyndall, Michael Vaughan, James Hall and Vesna Poljak
January 2007
Gene technique licence deal lifts Benitec
Shares in biotechnology group Benitec received a boost on Friday after Sigma-Aldrich, the exclusive licensee of its gene silencing technology, DNA-directed RNAi (ddRNAi), announced it had granted global pharmaceutical group Pfizer a worldwide non-exclusive research licence to use the technology. Gene silencing is used in drug development by the pharmaceutical industry, and ddRNAi is considered to have advantages over some of the alternative gene silencing technologies.
- Henry Byrne
April 2005
September 2004
Benitec takes on deadly genes
Benitec last week stitched up a research agreement with City of Hope, a leading cancer research and treatment centre in Los Angeles.
- James Eyers
December 2003
Benitec sees millions in genetic tool
Research agency CSIRO and listed biotechnology company Benitec are to jointly develop and license a genetic tool which could reap them hundreds of millions of dollars.
- Bill Pheasant